Lipophilicity, Hydrophilicity, and the Central Nervous System Side Effects of Beta Blockers
- 8 July 1987
- journal article
- review article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 7 (4) , 87-91
- https://doi.org/10.1002/j.1875-9114.1987.tb04029.x
Abstract
One of the attributes of beta‐adrenergic blocking agents that has distinguished these drugs from each other is degree of lipophilicity. While this feature may play a role in facilitating passage across the blood‐brain barrier, it is essential to realize that crossing the barrier is not necessarily synonymous with the ability to cause central nervous system (CNS) effects. Several studies have found some degree of CNS side effects, particularly tiredness and fatigue, with atenolol, a hydrophilic beta blocker. Pindolol, a moderately lipophilic beta blocker, has been reported to cause greater disturbances on electroencephalogram (EEG) than propranolol, the most highly lipophilic beta blocker. The investigational agent bevantolol exhibits a moderate degree of lipophilicity and a low frequency of CNS side effects. Drug‐induced increases in plasma catecholamine levels, the possible saturation of CNS receptor sites at relatively low drug levels, and the specific structural details of beta‐blocker molecules have been suggested as possible contributory factors in determining the degree of CNS effects.Keywords
This publication has 22 references indexed in Scilit:
- Renal hemodynamics and pharmacokinetics of bevantolol in patients with impaired renal functionThe American Journal of Cardiology, 1986
- Bevantolol Hydrochloride — Preclinical Pharmacologic ProfileAngiology, 1986
- Safety Profile of BevantololAngiology, 1986
- Clinical Consequences of the Lipophilicity and Plasma Protein Binding of Antiarrhythmic Drugs and Active Metabolites in ManAnnals of the New York Academy of Sciences, 1984
- Beta blockers in hypertensionThe American Journal of Cardiology, 1983
- Atenolol Therapy in Hypertensive PatientsDrugs, 1983
- β-Blocking Drugs and SleepDrugs, 1983
- β-Blockade and the Human Central Nervous SystemDrugs, 1983
- How Safe are β-Blockers?Drugs, 1983
- β-Adrenoceptor Antagonists: New Drugs and New IndicationsNew England Journal of Medicine, 1981